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Abstract
Introduction: Prevalence of menstrual dysfunction (MD) in high school athletes ranges from 7% to 54%. Early recognition and intervention are crucial to prevent future consequences. The purpose of this Quality Improvement project was to optimize the institution’s
Epic Best Practice Advisory (BPA) screening tool and synthesize new patient questionnaires to diagnose MD in athletes greater than
12 years of age presenting to a pediatric sports medicine clinic. Methods: Using Quality Improvement methodology, we evaluated
clinic flow, the Epic BPA tool, and actions by the physician following the appropriate triggering of the BPA. Diagnoses targeted were
primary amenorrhea, oligomenorrhea, or irregular menstruation unspecified. Areas for intervention were global staff education, patient
education, and provider alert fatigue. Our team implemented interventions using monthly Plan-Do-Study-Act cycles to address our
key drivers. Proper implementation of questionnaire data and restructuring of the Epic BPA promoted identification and diagnosis of
MD. The clinician discussed the diagnosis with the patient and family and provided an educational handout on MD. Results: The
rate of appropriate diagnosis of MD in athletes greater than 12 years of age seen at a pediatric sports medicine clinic increased from
a baseline of 2.1% to 30% over ten months. Identification of three key drivers ultimately drove the success and achievement of our
aim. Conclusions: Using Quality Improvement methodology, we optimized the EPIC BPA and subsequently increased the rate of
appropriate diagnosis of MD. Identification of the proper diagnosis improves our patient education. Ultimately, this project provided
the framework for applicable discussion, interventions, and work-up for at-risk athletes. (Pediatr Qual Saf 2022;7:e505; doi: 10.1097/
pq9.0000000000000505; Published online January 21, 2022.)

INTRODUCTION

growth, development, and overall functioning.2
Deviations from eumenorrhea can occur due
to a variety of medical conditions, comorbidities, in addition to extreme changes in
dietary or exercise patterns. Menstrual
dysfunction (MD) is a broad term for
these deviations and specifically includes
conditions such as primary amenorrhea,
anovulatory cycles, oligomenorrhea, and
secondary amenorrhea. The prevalence of
MD varies based on a variety of intrinsic and
extrinsic factors. The prevalence of secondary
amenorrhea varies with specific sports, age of the
athlete, the volume of training, and body weight/composition. In some studies, the prevalence is reported as high as
69% in a small group of professional ballet dancers and
65% in long-distance runners, compared with 2–5% in
large general population studies. In addition, the reported
prevalence of MD in high school athletes ranges from 7%
to 54%.3–6
Given its prevalence, associations, and long-term
health consequences, screening for MD, especially in
vulnerable populations such as athletes, is an essential
component of healthcare. Screening and subsequent
early detection of MD can prompt appropriate evaluation and intervention to prevent long-term consequences such as decreased bone mass, increased stress
fracture risk, increased rate of musculoskeletal injuries
with prolonged recovery time, endothelial dysfunction,
and future fertility effects.1,7–9 A recent study looking at

Background Knowledge

Menstrual function exists on a spectrum
ranging from eumenorrhea to amenorrhea.
In young adult women, menstrual cycles
recur at a median interval of 28 days with
a variable SD of 7 days, and in young adolescents can range from 21 to 45 days.1,2
Menstrual function can serve as an additional vital sign in the assessment of normal
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low bone mineral density in elite athletes showed that
secondary amenorrhea for at least 1 year during teenage years was strongly associated with low bone mineral
density (BMD) in the athletes’ early 20s.
MD is one component of the Female Athlete Triad
(Triad), in addition to decreased energy availability (with
or without disordered eating,) and low BMD. Having one
component of the Triad puts an athlete at an increased
risk for other components of the Triad.7 The Female
Athlete Triad coalition consensus statement recommends
that athletes undergo annual screening with the Triadspecific self-report questionnaire, followed by a more
in-depth evaluation if the athlete has or is at risk for any
Triad component.7
There are several difficulties inherent to screening for
MD that impact early detection and intervention. The
use of hormonal contraception, limitations in self-reporting, subclinical symptoms, and lack of patient and
clinician education regarding normal menstrual patterns
and consequences of MD significantly limit a clinician’s
diagnostic capability. In addition, there exists a lack of
knowledge in athletes regarding the relationship between
bone health, athletics, and menstrual patterns, which further impact disclosure and awareness of symptoms.10 In
a study investigating collegiate athletic trainers’ knowledge of the Female Athlete Triad and relative energy
deficiency in sports (RED-S), results indicated that while
these front line care providers can recognize some features of both the Triad and RED-S, more comprehensive
referral behaviors for MD and bone injury were more
often seen in Division I institutions than Division II or
III.11 Experts also question the appropriate setting, frequency, and methods of screening. The annual preparticipation physical exam (PPE) is the most commonly
recommended screening opportunity.7 The PPE may be
completed at the athlete’s annual well-visit, at an acute
care clinic, or through mass team or school physicals.
Although there is a current Preparticipation Physical
Exam Monograph 5th edition, there is no systematic
approach for implementation across the United States,
and many PPE forms lack appropriate screening questions. At both a high school and collegiate level, studies
have demonstrated that the standard PPE MD screening
questions may not effectively screen for the Triad based
on the recommendations from the Female Athlete Triad
Coalition.6,12

further evaluation of new patients who met criteria for
MD. Patients recorded their menstrual history on a paper
pre-visit questionnaire, and the certified athletic trainer
(ATC) or clinic assistant (CA) entered the data into the
electronic medical system, EPIC. The data triggered the
BPA if criteria for MD were met (See Table 1 for BPA
Criteria). As a component of this QI initiative, a retrospective chart review analyzing these BPA triggers over
2 years determined the correct application of that information with appropriate ICD 10 diagnosis of MD, as a
selected visit diagnosis occurred only 2.1% of the time for
the appropriate patients.

Relevant Published Investigations

There are several published reports regarding the use of
Clinical Decision Support (CDS) systems such as BPAs to
improve healthcare processes, medical decision-making,
guideline adherence, and medication dosing.14 Kucher et
al described the use of CDS alerts to encourage deep-vein
thrombosis (DVT) prophylaxis and successfully reduced
the number of symptomatic and asymptomatic DVTs in
hospitalized patients.15 Cecchini et al similarly used an
Epic BPA at their institution and reported improvement
in the rate of structured cancer staging as a direct consequence of electronic decision support.16 As with many
automated processes, there still exists room for error and
subsequent iatrogenic consequences. Studies report specifically on CDS-related treatment delays and the concept of
“alert fatigue” leading to unintended overriding of potentially critical notifications.14 However, in a recent systematic review of the efficacy and unintended consequences
of hard-stop alerts in electronic health record systems,
Powers et al concluded that 79% showed improvement in
health outcomes and 88% in process outcomes. Among
the studies that reported good user experience, heavy user
involvement and iterative design were cited.17
Within the Sports Medicine Department at our
Children’s Hospital, we have an appropriate CDS screening tool and unique opportunity to evaluate, diagnose,
and appropriately intervene to prevent long-term consequences of MD in athletes. The aim of this Quality
Improvement (QI) project was to optimize the institution’s current Epic BPA screening tool and synthesize new
patient questionnaire responses to diagnose MD in athletes greater than 12 years of age presenting to a pediatric
sports medicine clinic. Our specific goal was to increase
diagnoses from a baseline of 2.1% to 20% in 3 months
and sustain for 12 months. The QI initiative focused on
staff education, patients, and BPA redesign as key drivers
to achieve our aim.

Local Significance

Pediatric sports medicine is an outpatient subspecialty
service at Nationwide Children’s Hospital with eight different clinic sites serving patients in Columbus, Ohio, and
surrounding locations. In a prior study from our institution, the prevalence of menstrual dysfunction (MD)
among injured athletes presenting to a pediatric primary
care sports medicine clinic was 15.9% from October
2012 to May 2014.13 An Epic Best Practice Advisory
(BPA) was designed in May 2013 to identify and prompt

METHODS
Ethical Considerations

Institutional Review Board approval was not required
because this was a QI project involving retrospective chart review and prospective Plan-Do-Study-Act
2
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Table 1. MD BPA Criteria
MD BPA Triggers

BPA Message

Have you ever had a menstrual cycle?: No
Patient is older than 15 years at the time of visit?: Yes
Have you ever had a menstrual cycle?: Yes
Age is >1 year from menarche age?: Yes
Currently pregnant?: No
Patient on hormonal contraceptives?: No
Older than 35 days between cycles?: Yes
<9 Menses in last 12 months: No
Have you ever had a menstrual cycle?: Yes
Age is >1 year from menarche age?: Yes
Currently pregnant?: No
Patient on hormonal contraceptives?: No
Older than 35 days between cycles?: No
<9 Menses in last 12 months: Yes
Does Sport training affect your menstrual cycle?: No
Have you ever had a menstrual cycle?: Yes
Age is >1 year from menarche age?: Yes
Currently pregnant?: No
Patient on hormonal contraceptives?: No
Older than 35 days between cycles?: No
<9 Menses in last 12 months: No
Does Sport training affect your menstrual cycle?: Yes

POSSIBLE MENSTRUAL DYSFUNCTION
Based on the answers or missing information below, this patient has
been flagged for menstrual dysfunction

(PDSA) cycles and did not qualify as research involving
human subjects.

achieve our aim. Using QI methodology, we evaluated the
clinic workflow, Epic BPA tool, and actions by the physician following the appropriate firing of the MD BPA as
areas to investigate for process improvement. The team
constructed a process map of typical patient flow from
intake to discharge during a new encounter (Fig. 1). This
facilitated identification of potential process errors in our
clinical flow. Specifically, we recognized that the physician
could evaluate the patient before documentation of the
screening questionnaire in Epic. This potentially resulted
in a missed opportunity to diagnose and educate the
patient if the BPA triggers after the physician completed
the encounter with the patient. In addition, if electronic
documentation is delayed, incomplete, or incorrect, the
information serves as another missed opportunity.
The team also formulated a fishbone diagram documenting potential reasons for neglecting to record a MD
diagnosis—for example, if the Epic BPA tool fired appropriately but the BPA dialogue box included extraneous
patient data or complicated options. In discussions with
physicians on our QI team, the BPA design was cumbersome and difficult to navigate. It was programmed to pull
in laboratory data such as Vitamin D levels and chemistry panels that were often old or ordered during a time
of acute illness. This, in combination with “alert fatigue”
(a well-known phenomenon in the era of electronic
medical records), often led to the physician overriding
or ignoring the trigger and missing an opportunity to

Setting

Our Hospital’s Sports Medicine has 8 outpatient locations
in Columbus, Ohio, and the surrounding area. The sports
medicine department has nine attending physicians and a
primary care sports medicine fellow. In addition, the certified athletic trainers (ATCs) serve as physician extenders,
and CAs manage administrative tasks, patient rooming,
patient scheduling, and contribute to patient education.
In 2019, there were 17,533 patient visits at the Hospital’s
Sports Medicine clinics, with 7372 documented female
patients over the age of 12 years.

Data Collection and Definitions

A baseline percentage of appropriate diagnosis of MD
was established by retrospective chart review over 22
months for all clinic locations. We selected patient charts
if the BPA was triggered, indicating a positive screen for
MD, and assessed for the presence of an MD diagnosis
for that encounter. We defined appropriate MD diagnosis
according to criteria described in Table 2.

Interventions

Our multidisciplinary QI team included physicians,
ATCs, and CAs, allowing for a holistic view of clinic flow
and informed ways to improve the patient encounter to
Table 2. Definitions of MD and ICD 10 codes
Diagnosis

Definition

ICD 10 Codes

Primary Amenorrhea
Oligomenorrhea

Absence of menarche by age 15
Age >1 year post menarche and older than 35 days between cycles,
or <9 cycles in past 12 months
Training affects menstrual cycle

N91.0, N91.1, N91.2
N91.3, N91.4, N91.5

Irregular Menstruation Unspecified

Adapted with permission from World Health Organization (2004).
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Fig. 1. Flow diagram for pediatric sports medicine process from patient registration to discharge.

educate, diagnose, and possibly intervene on a patient
with MD. Ultimately, a key driver diagram demonstrated
our team’s specific aim, drivers, and interventions (Fig. 2).
The project’s unique drivers were staff education, patient
education, and Epic BPA redesign.
The established baseline rate of appropriate diagnosis of MD by retrospective chart review of BPA triggers
was 2.1% over 22 months. This was calculated by taking
the number of athletes who screened positive and had an
appropriate ICD 10 diagnosis associated with their visit
over the total number of athletes who screened positive.

The interventions developed for each key driver were
monthly Plan-Do-Study-Act cycles. The timing of the interventions described are noted in Figure 2. A presentation
was prepared and delivered at a staff meeting highlighting menstrual function education, an in-depth look at the
patient questionnaire, and emphasizing the importance of
real-time electronic documentation in the patient chart to
ensure timeliness of BPA trigger. In addition, an educational
handout was created and electronically linked to patient
care instructions in the After Visit Summary for each new
patient MD diagnosis. This handout promoted patient

Fig. 2. Key driver diagram showing the three key drivers and various interventions to achieve the aim.

4

Daniel et al • Pediatric Quality and Safety (2022) 7:1;e505

www.pqs.com

DISCUSSION

education, appropriate follow-up, and empowered athletes
to understand the immediate and long-term consequences
of MD. The simplified BPA included only the triggering
information that suggested diagnostic criteria for MD, and
a new streamlined Smart Set gave only the diagnosis suggested based on screening parameters (Table 1).

Increasing appropriate diagnosis of MD in athletes presenting to a pediatric sports medicine clinic proved to be
an attainable goal with efforts directed toward staff education, patient education, and redesigning the Epic BPA.
Overall, this QI project increased awareness of MD as a
significant concern for athletes. We addressed this comprehensively through cultivating both educational initiatives and creating open dialogue to discuss the issue at
the patient/family, staff, and physician level. QI data were
reviewed monthly during department meetings to encourage awareness, participation, and to gather feedback.
Through our staff education, we empowered ATCs and
CAs to use the patient intake process as an opportunity to
investigate and educate in an efficient manner. As demonstrated in Figure 3, this resulted in an immediate increase
in appropriate screening and diagnosis. Patients and family members were encouraged to ask questions about the
intake form and screening questions as staff prioritized
accuracy and completion of pertinent information. This
initial interaction was essential in creating a dialogue
about menstrual function and ensuring accurate information to electronically document and promptly alert the
physician before visit with the patient.
The increased documentation of accurate information regarding menstrual function facilitated open and

Data Analysis

Our primary outcome measure was the percentage of eligible patients with an ICD 10 diagnosis of MD entered
when the criteria (Table 1) was met. The baseline percentage was 2.1%. Baseline data were entered into a control
chart (p-chart), and centerline (mean) and control limits
(±3 SD, representing inherent variation) were calculated.
Data were recorded on each subsequent month, and standard control chart rules were used to identify special versus common cause variation and if a centerline shift was
warranted.

RESULTS
We achieved and surpassed our aim of reaching an
appropriate MD diagnostic rate of 20% in January 2020
(Fig. 3). After our third intervention in December 2019,
we continued to increase our diagnosis rate in the subsequent months with a solid centerline shift above our aim.

Fig. 3. Control chart (p-chart) demonstrating the percentage of patients with the appropriate MD diagnosis (y axis) over each month
(x axis).
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informative patient–physician discussions concerning
the etiology, associated risk factors, and consequences of
MD. Similar to any other vital sign, our physicians were
encouraged to consider menstrual function as a component of objective data when evaluating their athletes
because it can have multiple effects on a variety of musculoskeletal pathology. While often included in discussions
surrounding stress injuries, MD was now a discussion
to incorporate into all anticipatory guidance with new
musculoskeletal injuries and concussions. The handout
provided to all newly diagnosed patients re-enforced
information shared by the physician and included important recommendations for prevention and follow-up care.
In addition to prompting immediate education and recommendations for prevention and possible interventions
for the patient, documenting the appropriate diagnosis
of MD alerts other medical providers of an important
finding with profound health impacts. Any provider with
access to the medical chart, such as primary care physicians, athletic trainers or other subspecialty physicians,
will be able to identify the athlete’s diagnosis, evaluation,
pertinent work-up and be better able to appreciate how
MD may impact other concomitant medical conditions.
In reviewing the literature, the specific questionnaire and
environment in which the screening for MD takes place
are the targets to optimize so as to increase MD diagnosis
in athletes. The current Preparticipation Physical Exam
Monograph 5th edition includes four questions that are
specific to screening for MD.18 The Female Athlete Triad
Coalition recommends annual screening for Triad risk
factors with a Triad-specific self-report questionnaire,
which includes questions unique to MD.7 There is limited
evidence regarding the efficacy of PPE forms in screening
for triad risk factors, including MD.12 Young et al specifically investigated the efficacy of the PPE in screening
for MD by comparing it with another validated tool, the
Healthy Wisconsin High School Female Athlete Survey.
They found a high degree of inconsistency of participants’
answers between the standard PPE form and the Healthy
Wisconsin High School Female Athlete Survey. This study
challenges the validity and reliability of the standard PPE
form and prompts further research into the quality of the
questionnaire as a screening tool. The American Academy
of Pediatrics and the American College of Obstetrics and
Gynecology recommend the evaluation of menstrual
cycles as part of the routine vital sign assessment in a
preventative healthcare office visit to increase diagnosis
of MD, educate patients and family, and encourage them
to take responsibility for their own reproductive health.2
There does not exist a standardized office protocol or specific study validating this recommendation or identifying
other unique tools to increase the diagnosis of MD.
This study further shows that the appropriate use of
CDS systems can improve the rate of MD diagnosis and
supports the expanding literature recognizing the important role of CDS in improving processes. In their review
article on CDS systems, Beeler et al identified certain

crucial features of a successful CDS intervention, including providing decision support automatically as part of clinician workflow, providing actionable recommendations,
and justification of decision support via research evidence
and local user involvement.14 Our re-designed Epic BPA
has these unique features and, when appropriately used
by the physician, improves the accurate diagnosis of MD.
As discussed in monthly Plan-Do-Study-Act review
cycles, this QI project did not have a detrimental effect on
overall clinic workflow, and likely improved the accuracy
and efficiency of our new patient intake process. In reviewing feedback from other published CDS QI studies, our
initiative did share similar negative feedback from users,
including anticipation of extra time for physician documentation and education and dependence on timeliness of
data entry to prompt firing of the BPA alert. As a retrospective chart review, this study was prone to observer bias if
the charts were not analyzed correctly; however, this was
minimized by using strict criteria and specific ICD diagnostic codes. We did not include “secondary amenorrhea”
as a diagnostic code because we felt that further diagnostic
work-up is needed to use that diagnosis, and this was not
investigated in this study. We used greater than 35 days
in between cycles as criteria for oligomenorrhea, per the
Female Athlete Triad Consensus panel. As mentioned earlier, more recent publications, including those from the
American Academy of Pediatrics and American College
of Obstetrics and Gynecology, state that cycles occurring
at intervals greater than 45 days meet criteria for oligomenorrhea. Therefore, our screening BPA tool is likely
more sensitive than recent guidelines suggest. In addition,
beginning in March 2020, our new patient visits were significantly impacted by the COVID-19 pandemic. The pandemic affected the number of new patient visits and our
screening, documentation, and clinic workflow with our
transition to Telehealth visits. However, we did continue
to observe a positive trend in diagnosis despite unavoidable limitations from the pandemic.
The aim of this study was to increase the appropriate
diagnosis of MD, through a unique CDS, in athletes presenting to a pediatric sports medicine clinic. We determined that appropriate diagnosis is a critical first step of
a comprehensive evaluation of MD. In our discussions
with patients and educational handouts we recommend
follow-up with two of our attending physicians who have
expertise in the care of the athlete or further evaluation
with a primary care physician. In this study we did not
collect data on subsequent actions, evaluation, or referrals placed after the diagnosis was made. This will be a
crucial next step for future research to optimize care and
positive outcomes for athletes.

CONCLUSIONS
Our goal was to increase the appropriate diagnosis of
MD in athletes presenting to a pediatric sports medicine
clinic. We increased our rate of diagnosis over 6 months.
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Education and optimization of CDS systems were essential in achieving this goal. We intend to maintain this QI
initiative and continue to improve our accurate diagnosis of MD to empower our athletes. Similar to the ultimate goal of CDS in healthcare, the future direction of
this initiative is to affect patient outcomes. Appropriate
identification and diagnosis of MD warrants subsequent
evaluation and interventions.
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